Rankings
▼
Calendar
RLAY FY 2022 Earnings — Relay Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
RLAY
Relay Therapeutics, Inc.
$2B
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
-54.4% YoY
Gross Profit
$1M
100.0% margin
Operating Income
-$299M
-21670.9% margin
Net Income
-$291M
-21036.1% margin
EPS (Diluted)
$-2.59
Cash Flow
Operating Cash Flow
-$229M
Free Cash Flow
-$239M
Stock-Based Comp.
$56M
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$150M
Stockholders' Equity
$950M
Cash & Equivalents
$999M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$3M
-54.4%
Gross Profit
$1M
$3M
-54.4%
Operating Income
-$299M
-$365M
+17.9%
Net Income
-$291M
-$364M
+20.2%
← Q4 2021
All Quarters
Q1 2022 →